As a result, based on the role of OGN in cancer and its potential as a biomarker, in this study, the role of this gene in PRCC has been shown for the first time, and based on the ROC curve, it is possible for it to be used alone or in combination with two other genes—BCL11A and NTN5—to detect this disease. The gene discussed is BCL11A; the disease is cancer.